HHTM's mission is to bridge the knowledge gaps in treating hearing loss by providing timely information and lively insights to anyone who cares about hearing loss. Our contributors and readers are drawn from many sectors of the hearing field, including practitioners, researchers, manufacturers, educators, and, importantly, consumers with hearing loss and those who love them.
Featured image for “Are Captions More Accessible on the Top of the Screen?”
Sep. 27, 2022

Are Captions More Accessible on the Top of the Screen?

HHTM
Where should the caption window be located for the best accessibility? I had not given this issue much thought until my recent visit to Washington DC. It was a terrific trip. We toured the U.S. Capital and enjoyed many wonderful museums including the newest addition to the Smithsonian, the National Museum of African American History and Culture. Everywhere we visited was
Featured image for “Voting Is Now Open for 2022 Oticon Focus on People Awards”
Sep. 26, 2022

Voting Is Now Open for 2022 Oticon Focus on People Awards

HHTM
SOMERSET, NEW JERSEY – Voting is now open for the 2022 Oticon Focus on People Awards at Oticon.com/FOP . Website visitors are invited to cast their votes for the 12 finalists who represent the “best of the best” from this year’s nominations in each of four categories – Student, Adult, Advocacy and Practitioner. The total number of votes received by
Featured image for “On the Fly Mobile Captioning: Hi There Solutions New Live Voice to Text Apps”
Sep. 26, 2022

On the Fly Mobile Captioning: Hi There Solutions New Live Voice to Text Apps

HHTM
John and Chase Prieve are a father-son duo who also happen to be co-founders of the start-up mobile app, Hi There Solutions. They sit down with Brian Taylor to discuss their motivation for creating this suite of live voice to text apps and describe how it can be used by persons with a range of hearing losses to more effectively
Featured image for “New Study Challenges Current Knowledge About How Inner Ear Detects Low-Frequency Sound”
Sep. 25, 2022

New Study Challenges Current Knowledge About How Inner Ear Detects Low-Frequency Sound

HHTM
Scientists have discovered the cochlea in the inner ear detects low-frequency sound in a manner very different than previously known, according to new research from scientists at Oregon Health & Science University and Linköping University in Sweden. The finding, published in the journal Science Advances, may make it possible to design better cochlear implants for people with hearing impairments. “It was an
Featured image for “Noah ES Surpasses 500 User Milestone”
Sep. 22, 2022

Noah ES Surpasses 500 User Milestone

HHTM
COPENHAGEN, DENMARK – HIMSA has announced that Noah ES, its new cloud-enabled Noah solution released last February in the USA and Europe, has now surpassed the 500 user milestone. Since its release seven months ago, Noah ES has steadily grown, and cloud performance has steadily improved. “When talking to our Noah ES users, one of the highlights they mention with
Featured image for “FDA Approves PEDMARK® to Reduce Hearing Loss Risk in Pediatric Patients Undergoing Cisplatin Chemotherapy”
Sep. 21, 2022

FDA Approves PEDMARK® to Reduce Hearing Loss Risk in Pediatric Patients Undergoing Cisplatin Chemotherapy

HHTM
RESEARCH TRIANGLE PARK, NORTH CAROLINA — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved PEDMARK® (sodium thiosulfate injection) to reduce the risk of ototoxicity associated with cisplatin in pediatric patients one month of age and older with localized, non-metastatic solid tumors. This approval makes PEDMARK the
Featured image for “Successfully Integrating Remote Care into an Audiology Practice with Dr. Michael Valente”
Sep. 21, 2022

Successfully Integrating Remote Care into an Audiology Practice with Dr. Michael Valente

HHTM
Dr. Michael Valente returns to discuss how remote care and remote fine tuning can help address issues of accessibility and convenience for patients. He’ll explain the importance of why audiology practices should implement these options in their service offering to differentiate their clinic in a post-OTC era. Readers may also be interested Part 1 and Part 2 of this series
Featured image for “Decibel Therapeutics Announces Submission of IND Application for Lead Gene Therapy Candidate DB-OTO”
Sep. 20, 2022

Decibel Therapeutics Announces Submission of IND Application for Lead Gene Therapy Candidate DB-OTO

HHTM
BOSTON, MASSACHUSSETTS — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for a Phase 1/2 clinical trial in pediatric patients of DB-OTO, a gene therapy product candidate
Featured image for “FCOM 2022 to Take Place in Boca Raton, November 11-13”
Sep. 20, 2022

FCOM 2022 to Take Place in Boca Raton, November 11-13

HHTM
The Florida Combined Otolaryngology Meeting (FCOM) includes the Florida Society of Otolaryngology Head and Neck Surgery (FSO-HNS), the Florida Society of Facial Plastic and Reconstructive Surgery (FSFPRS), the Network of Florida Otolaryngologists (NFO) and the Network of Medical Audiology Professionals (MedAudPro) has a speaker lineup of more than 120 presenters for its 26th annual meeting. The primary event will take
Featured image for “Breaking Down the FDA’s Final OTC Hearing Aid Guidelines with Dr. David Akbari”
Sep. 19, 2022

Breaking Down the FDA’s Final OTC Hearing Aid Guidelines with Dr. David Akbari

HHTM
The recent release of the final FDA guidelines on over-the-counter (OTC) and prescriptive hearing aid categories is detailed and complex.  In this episode, Amyn Amlani is joined by David Akbari, Senior Medical Science, Clinical and Regulatory Affairs Liaison at Intricon Corporation, to help breakdown the new regulations.   Dr. Akbari provides the audience with an overview of the guidelines and